Eli Lilly and Company (NYSE:LLY | LLY Price Prediction) and Novo Nordisk A/S (NYSE:NVO) reported quarterly results in early ...
StockStory.org on MSN
Branded pharmaceuticals stocks Q4 teardown: Royalty Pharma (NASDAQ:RPRX) vs the rest
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...
Mon, February 16, 2026 at 7:00 PM UTC As of February 13, 2026, shares of Eli Lilly (NYSE:LLY) were trading at $1,040, just 5.8% below the stock's all-time high. Retail sentiment has turned decisively ...
Eli Lilly topped Novo in terms of both revenue and net income. Moderna’s stable financials were overshadowed by the regulatory whiplash it experienced in mid-February. Similarly, the vaccine segments ...
StockStory.org on MSN
Q4 earnings highs and lows: Pfizer (NYSE:PFE) vs the rest of the branded pharmaceuticals stocks
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...
Eli Lilly (LLY) beat Q4 EPS estimates by 12%. Zepbound holds nearly 70% of new obesity prescriptions. Lilly CEO and 12 executives collectively purchased $104M in shares during February. Lilly expects ...
Bristol Gate Capital Partners, an investment management company, published its Q4 2025 investor letter for the “US Equity Strategy”. A copy of the letter can be downloaded here. Bristol Gate ...
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results